Nimbus Synergies is pleased to announce the completion of a $2.26 million follow-on investment in portfolio company Arbutus Medical. This investment was led by Nimbus Synergies and Genome BC’s Industry… Read More
VANCOUVER, BC — Genome British Columbia (Genome BC) has invested $1.13 million into Arbutus Medical Inc., a BC-based medical device company developing innovative surgical drill technology and procedure kits that improve hospital… Read More
Over $700 million investment doubles down on driving innovation The Government of Canada is spurring economic growth, helping create well-paying jobs and growing our competitive advantage by investing in ideas,… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces it… Read More
New bioaccelerator to grow biomanufacturing capacity for Canada CHARLOTTETOWN, PE – The Governments of Canada and Prince Edward Island today announced a $50 million investment in the BioAccelerator, the largest… Read More
